Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)-2-pyrrolidinone
2. 2-pyrrolidinone, 4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)-1,3,4-thiadiazol-5-yl)methyl)-, (4r)-
1. 1294000-61-5
2. Padsevonil [inn]
3. Padsevonil [usan]
4. Ucb0942
5. Ucb-0942
6. Ucb1415943-000
7. 0r1hn52k0n
8. Ucb-1415943-000
9. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)pyrrolidin-2-one
10. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one
11. 2-pyrrolidinone, 4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)-1,3,4-thiadiazol-5-yl)methyl)-, (4r)-
12. Padsevonil [jan]
13. Padsevonil (jan/usan)
14. Padsevonil [who-dd]
15. Unii-0r1hn52k0n
16. Schembl1672843
17. Chembl4297521
18. Ex-a5541
19. Who 10384
20. Db14977
21. Hy-109009
22. Cs-0030507
23. D11842
24. Q27237119
25. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)-2-pyrrolidinone
Molecular Weight | 432.8 g/mol |
---|---|
Molecular Formula | C14H14ClF5N4O2S |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 6 |
Exact Mass | 432.0446154 g/mol |
Monoisotopic Mass | 432.0446154 g/mol |
Topological Polar Surface Area | 88 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 572 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
ABOUT THIS PAGE
65
PharmaCompass offers a list of Padsevonil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Padsevonil manufacturer or Padsevonil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Padsevonil manufacturer or Padsevonil supplier.
PharmaCompass also assists you with knowing the Padsevonil API Price utilized in the formulation of products. Padsevonil API Price is not always fixed or binding as the Padsevonil Price is obtained through a variety of data sources. The Padsevonil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Padsevonil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Padsevonil, including repackagers and relabelers. The FDA regulates Padsevonil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Padsevonil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Padsevonil supplier is an individual or a company that provides Padsevonil active pharmaceutical ingredient (API) or Padsevonil finished formulations upon request. The Padsevonil suppliers may include Padsevonil API manufacturers, exporters, distributors and traders.
Padsevonil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Padsevonil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Padsevonil GMP manufacturer or Padsevonil GMP API supplier for your needs.
A Padsevonil CoA (Certificate of Analysis) is a formal document that attests to Padsevonil's compliance with Padsevonil specifications and serves as a tool for batch-level quality control.
Padsevonil CoA mostly includes findings from lab analyses of a specific batch. For each Padsevonil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Padsevonil may be tested according to a variety of international standards, such as European Pharmacopoeia (Padsevonil EP), Padsevonil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Padsevonil USP).